Pass
Pass
Archive: https://archive.today/8ohWq
From the post:
>The FDA has lifted a pause on the administration of a vaccine for the chikungunya virus, a mosquito-borne illness currently spreading from China. The Ixchiq single-dose vaccine was approved for adults 18 and up at risk of exposure to the virus in 2023, when the CDC had recorded 152 travel-associated cases of the virus, the highest rate in four years. But administrations of the shot to adults aged 60 and older were paused in May of this year, triggered by reports of 17 serious side effects following vaccination, including two deaths. Most of the reported issues were neurological or cardiac, and all involved people over 60. Six cases were reported in the US, with the remaining cases among the tens of thousands of people vaccinated worldwide. However, on August 7, the FDA greenlit the vaccine again for adults 60 and up. While the agency did not say whether the lifted pause is related to an uptick in infections, the chikungunya virus is spreading globally.
Archive: https://archive.today/8ohWq
From the post:
>>The FDA has lifted a pause on the administration of a vaccine for the chikungunya virus, a mosquito-borne illness currently spreading from China.
The Ixchiq single-dose vaccine was approved for adults 18 and up at risk of exposure to the virus in 2023, when the CDC had recorded 152 travel-associated cases of the virus, the highest rate in four years.
But administrations of the shot to adults aged 60 and older were paused in May of this year, triggered by reports of 17 serious side effects following vaccination, including two deaths.
Most of the reported issues were neurological or cardiac, and all involved people over 60. Six cases were reported in the US, with the remaining cases among the tens of thousands of people vaccinated worldwide.
However, on August 7, the FDA greenlit the vaccine again for adults 60 and up. While the agency did not say whether the lifted pause is related to an uptick in infections, the chikungunya virus is spreading globally.
(post is archived)